Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation with isoflurane vs propofol in invasively ventilated ICU patients using AnaConDa
2016-004551-67Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jan 2017
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of isoflurane in None (2 arms), sponsored by Sedana Medical. Primary endpoint: Adequate sedation time without rescue sedation (isoflurane vs propofol). Started Jan 2017; status: completed.
02
Drugs
isoflurane
Beyond the preview
Go deeper on 2016-004551-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004551-67.